RUBIUS THERAPEUTICS

Rubius Therapeutics is creating RCTs™ as a new class of medicines. Leading applications include programs in cancer, enzyme deficiency diseases and the induction of tolerance to treat autoimmune disease. The company was conceived and launched by Flagship VentureLabs®, the innovation foundry where a team of scientific entrepreneurs systematically evolve enterprising ideas based upon previously undiscovered areas of science into real-world inventions and ventures.

#SimilarOrganizations #People #Financial #Event #Website #More

RUBIUS THERAPEUTICS

Social Links:

Twitter

Industry:

Biotechnology Health Care Pharmaceutical Therapeutics

Founded:

2013-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.rubiustx.com

Total Employee:

101+

Status:

Active

Contact:

(617)218-1606

Email Addresses:

[email protected]

Total Funding:

445 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics

Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

northstar-medical-radioisotopes-logo

NorthStar Medical Radioisotopes

NorthStar Medical Radioisotopes develops technologies and raw materials for the nuclear medicine market.

Current Advisors List

anne-prener_image

Anne Prener Independent Director of the Board @ Rubius Therapeutics
Board_member
2019-12-01

michael-rosenblatt_image

Michael Rosenblatt Board Member @ Rubius Therapeutics
Board_member

robert-langer_image

Robert Langer Board Member @ Rubius Therapeutics
Board_member

jonathan-symonds_image

Jonathan Symonds Board Member @ Rubius Therapeutics
Board_member

natalie-holles_image

Natalie Holles Board Member @ Rubius Therapeutics
Board_member

noubar-afeyan_image

Noubar Afeyan Board Member @ Rubius Therapeutics
Board_member
2014-01-01

francis-cuss_image

Francis Cuss Board Member @ Rubius Therapeutics
Board_member

catherine-sohn_image

Catherine Sohn Board Member @ Rubius Therapeutics
Board_member
2018-01-01

Current Employees Featured

not_available_image

Robert J Deans
Robert J Deans Chief Scientific Officer @ Rubius Therapeutics
Chief Scientific Officer

pablo-cagnoni_image

Pablo Cagnoni
Pablo Cagnoni Chief Executive Officer @ Rubius Therapeutics
Chief Executive Officer
2018-06-01

kelly-burke_image

Kelly Burke
Kelly Burke Senior Talent Acquisition Partner @ Rubius Therapeutics
Senior Talent Acquisition Partner
2022-03-01

maiken-keson-brookes_image

Maiken Keson Brookes
Maiken Keson Brookes Chief Legal Officer and Corporate Secretary @ Rubius Therapeutics
Chief Legal Officer and Corporate Secretary
2019-11-01

noubar-afeyan_image

Noubar Afeyan
Noubar Afeyan Co-Founder & Board Member @ Rubius Therapeutics
Co-Founder & Board Member
2014-01-01

greg-whitehead_image

Greg Whitehead
Greg Whitehead Chief Quality Officer @ Rubius Therapeutics
Chief Quality Officer

jiuyi-lu_image

Jiuyi Lu
Jiuyi Lu Director, Upstream Process Development @ Rubius Therapeutics
Director, Upstream Process Development
2021-12-01

frederico-lourenco_image

Frederico Lourenco
Frederico Lourenco Senior Director, Corporate Development and Strategy @ Rubius Therapeutics
Senior Director, Corporate Development and Strategy
2021-01-01

david-epstein_image

David Epstein
David Epstein Chairman Of The Board @ Rubius Therapeutics
Chairman Of The Board
2017-01-01

pablo-j-cagnoni_image

Pablo J. Cagnoni
Pablo J. Cagnoni Chief Executive Officer @ Rubius Therapeutics
Chief Executive Officer

Founder

avak-kahvejian_image

Avak Kahvejian

noubar-afeyan_image

Noubar Afeyan

Stock Details

Company's stock symbol is NASDAQ:RUBY

Investors List

flagship-ventures_image

Key Employee Changes

Date	New article
2021-08-30	Rubius Therapeutics Appoints Jim Jogerst as Chief Business Officer

Official Site Inspections

http://www.rubiustx.com Semrush global rank: 3.46 M Semrush visits lastest month: 4.41 K

Host Informations
Whois Informations

Loading ...